ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements
Daikaffil Chemicals India Limited held its 34th Annual General Meeting on September 22, 2026, to conduct ordinary business, including the adoption of financial statements.
The company has sent a letter to unregistered shareholders providing a web-link to the Annual Report 2025-26, alongside a routine KYC update reminder.
Daikaffil Chemicals India Limited has issued the notice for its 34th Annual General Meeting. The meeting is scheduled to be held on September 22, 2026.
Daikaffil Chemicals India Ltd reported revenue from operations of ₹1 Cr (-74.4% YoY) and a net loss of ₹0.6 Cr for Q1 FY27.
Daikaffil Chemicals India Limited has scheduled a board meeting for August 14, 2026. The board will consider and approve unaudited financial results for the June quarter.
Daikaffil Chemicals India Ltd has submitted its quarterly shareholding pattern for the period ended June 30, 2026, pursuant to SEBI Listing Regulations.
Daikaffil Chemicals approved revised FY26 consolidated financial results to include the missing Cash Flow statement. There were no changes to the previously reported financial performance figures.
Daikaffil Chemicals scheduled a board meeting for July 14, 2026. The board will consider revised FY26 results to include the consolidated cash flow statement.
Mikusu India Pvt Ltd, a promoter entity, acquired 8,144 equity shares of Daikaffil Chemicals India Ltd via open market on June 11, 2026. This increases promoter holding from 49.12% to 49.26%, signaling continued promoter confidence.
Promoter group entity Mikusu India Private Limited acquired 4,200 shares of Daikaffil Chemicals India Limited. The open market purchase increases their stake to 48.55%.
Daikaffil Chemicals India Limited re-appointed M/s SPSJ & Associates LLP as Internal Auditors for FY 2026-27. This ensures continued compliance and internal control oversight.
Daikaffil Chemicals India Ltd reported revenue from operations of ₹2 Cr and a net loss of ₹0.9 Cr for Q4 FY26.
Daikaffil Chemicals India reported audited annual results with total income reaching ₹13.40 Crore. The Board also re-appointed SPSJ & Associates LLP as internal auditors.
Daikaffil Chemicals India Ltd scheduled a board meeting for May 28, 2026. The board will consider standalone and consolidated audited financial results for FY2026.
Daikaffil Chemicals India Limited confirmed it does not meet the 'Large Corporate' criteria for FY 2026-27 under SEBI norms. The company reported zero outstanding long-term borrowings as of March 31, 2026. Consequently, mandatory debt sourcing requirements are not applicable.
Daikaffil Chemicals India Limited submitted its quarterly certificate under Regulation 74(5) for the period ended March 31, 2026. The registrar, MUFG Intime India, confirmed that security certificates received for dematerialisation were processed and substituted in the register of members within prescribed timelines. This is a routine regulatory disclosure.